- freely available
- re-usable
Pharmaceuticals 2010, 3(10), 3186-3199; doi:10.3390/ph3103186
Review
The Biochemical Basis of Hydroxymethylglutaryl-CoA Reductase Inhibitors as Neuroprotective Agents in Aneurysmal Subarachnoid Hemorrhage
Department of Surgery, Prince of Wales Hospital, Shatin, NT, Hong Kong, China
* Author to whom correspondence should be addressed.
Received: 30 August 2010; in revised form: 29 September 2010 / Accepted: 11 October 2010 / Published: 12 October 2010
Abstract: Aneurysmal subarachnoid hemorrhage (SAH) has the highest morbidity and mortality rates of all types of stroke. Many aneurysmal SAH patients continue to suffer from significant neurological morbidity and mortality directly related to delayed cerebral ischemia. Pilot clinical studies of the use of Hydroxymethylglutaryl-CoA Reductase Inhibitors (statins) in aneurysmal SAH patients have reported a reduction in delayed cerebral ischemia and better clinical outcomes. We review the biochemical effects of statins on endothelium vascular function, glutamate-mediated neurotoxicity, inflammatory changes, and oxidative injuries, with reference to their possible neuroprotective effects in aneurysmal SAH.
Keywords: aneurysm; hydroxymethylglutaryl-CoA reductase inhibitors; neuroprotective agent; subarachnoid hemorrhage
Article Statistics
Click here to load and display the download statistics.Cite This Article
MDPI and ACS Style
Wong, G.K.C.; Poon, W.S. The Biochemical Basis of Hydroxymethylglutaryl-CoA Reductase Inhibitors as Neuroprotective Agents in Aneurysmal Subarachnoid Hemorrhage. Pharmaceuticals 2010, 3, 3186-3199.
AMA StyleWong GKC, Poon WS. The Biochemical Basis of Hydroxymethylglutaryl-CoA Reductase Inhibitors as Neuroprotective Agents in Aneurysmal Subarachnoid Hemorrhage. Pharmaceuticals. 2010; 3(10):3186-3199.
Chicago/Turabian StyleWong, George Kwok Chu; Poon, Wai Sang. 2010. "The Biochemical Basis of Hydroxymethylglutaryl-CoA Reductase Inhibitors as Neuroprotective Agents in Aneurysmal Subarachnoid Hemorrhage." Pharmaceuticals 3, no. 10: 3186-3199.
Pharmaceuticals
EISSN 1424-8247
Published by MDPI AG, Basel, Switzerland
RSS
E-Mail Table of Contents Alert
